NDC product
Alka-Seltzer Gold
NDC 0280-4100 · Bayer HealthCare LLC.
Key facts
| Product NDC | 0280-4100 |
|---|---|
| Proprietary name | Alka-Seltzer Gold |
| Nonproprietary name | Alka-Seltzer Gold |
| Substances | CITRIC ACID MONOHYDRATE, POTASSIUM BICARBONATE, SODIUM BICARBONATE |
| Dosage form | TABLET, EFFERVESCENT |
| Route | ORAL |
| Labeler | Bayer HealthCare LLC. |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M001 |
| Pharmacologic classes | Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE] and 5 more |
| Marketing start | Nov 19, 2014 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: